Lactic acid bacteria, methods and uses thereof
AssigneeBiogaia AB
InventorStefan Roos
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel strains of lactic acid bacteria, more specifically, novel strains of Lactobacillus reuteri, capable of utilizing ethanolamine. This characteristic makes it possible for the bacteria to compete for the same substrate as pathogenic ethanolamine-utilizing pathogens, thereby presenting an effective means to combat infections resulting from such pathogenic bacteria. There is also provided a method of selecting further ethanolamine-utilizing lactic acid bacteria, as well as other methods and uses involving said novel strains and other ethanolamine-utilizing lactic acid bacteria.
Claims7
A composition comprising frozen and/or lyophilized probiotic Lactobacillus reuteri DSM 27131 and one or more of a cryoprotectant and/or a lyoprotectant.
A biologically pure culture of Lactobacillus reuteri DSM 32465.
A composition comprising probiotic Lactobacillus reuteri DSM 32465 and one or more of a cryoprotectant and/or a lyoprotectant.
A method for treating or reducing the risk of developing a condition or disorder caused by or related to an ethanolamine-utilizing pathogen in a subject in need thereof, said method comprising administering an effective amount of a composition comprising Lactobacillus reuteri DSM 32465 and/or Lactobacillus reuteri DSM 27131 to the subject.
Dependencies are inferred from the claim text.